WuXi NextCODE Genomics USA Inc. is expanding its Massachusetts presence with a lab in Woburn, a move that will complement its Kendall Square headquarters .

The international bioinformatics firm announced this morning that it has leased 5,000 square feet at 2 Gill St. from Cummings Properties. It maintains additional facilities in Shanghai, China and Reykjavik, Iceland.

WuXi NextCODE formed in 2015 when Chinese firm WuXiAppTec acquired NextCODE, a startup spun out from deCODE Genomics. Its clients, including Boston Children’s Hospital, Harvard Medical School and the DNA testing company 23andme, use its platforms for storing, sharing and interpreting massive sets of genomic data.

Fast Company named WuXi NextCODE to its 2018 list of “The World’s Most Innovative Companies.”

The global firm selected the Gill Street site due to its existing infrastructure and its location within a science-centric community, according to Leasing Officer Steve Cusano of Cummings Properties, who worked directly with WuXi NextCODE on the lease.

“More and more firms are realizing that a thriving biotech cluster as well as significant cost savings are available to them here in Woburn,” Cusano said in a statement.

WuXi NextCODE will join Medtronic, MitraBiotech, Pellion Technologies and other biotech firms in the Gill Street area.